Literature DB >> 15321997

Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4.

Richard P Darveau1, Thu-Thao T Pham, Kayde Lemley, Robert A Reife, Brian W Bainbridge, Stephen R Coats, William N Howald, Sing Sing Way, Adeline M Hajjar.   

Abstract

The innate host response to lipopolysaccharide (LPS) obtained from Porphyromonas gingivalis is unusual in that different studies have reported that it can be an agonist for Toll-like receptor 2 (TLR2) as well as an antagonist or agonist for TLR4. In this report it is shown that P. gingivalis LPS is highly heterogeneous, containing more lipid A species than previously described. In addition, purification of LPS can preferentially fractionate these lipid A species. It is shown that an LPS preparation enriched for lipid A species at m/z 1,435 and 1,450 activates human and mouse TLR2, TLR2 plus TLR1, and TLR4 in transiently transfected HEK 293 cells coexpressing membrane-associated CD14. The HEK cell experiments further demonstrated that cofactor MD-2 was required for functional engagement of TLR4 but not of TLR2 nor TLR2 plus TLR1. In addition, serum-soluble CD14 effectively transferred P. gingivalis LPS to TLR2 plus TLR1, but poorly to TLR4. Importantly, bone marrow cells obtained from TLR2(-/-) and TLR4(-/-) mice also responded to P. gingivalis LPS in a manor consistent with the HEK results, demonstrating that P. gingivalis LPS can utilize both TLR2 and TLR4. No response was observed from bone marrow cells obtained from TLR2 and TLR4 double-knockout mice, demonstrating that P. gingivalis LPS activation occurred exclusively through either TLR2 or TLR4. Although the biological significance of the different lipid A species found in P. gingivalis LPS preparations is not currently understood, it is proposed that the presence of multiple lipid A species contributes to cell activation through both TLR2 and TLR4.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15321997      PMCID: PMC517442          DOI: 10.1128/IAI.72.9.5041-5051.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  63 in total

1.  Cell activation by Porphyromonas gingivalis lipid A molecule through Toll-like receptor 4- and myeloid differentiation factor 88-dependent signaling pathway.

Authors:  Tomohiko Ogawa; Yasuyuki Asai; Masahito Hashimoto; Osamu Takeuchi; Tomoko Kurita; Yasunobu Yoshikai; Kensuke Miyake; Shizuo Akira
Journal:  Int Immunol       Date:  2002-11       Impact factor: 4.823

2.  Human Toll-like receptor 4 recognizes host-specific LPS modifications.

Authors:  Adeline M Hajjar; Robert K Ernst; Jeff H Tsai; Christopher B Wilson; Samuel I Miller
Journal:  Nat Immunol       Date:  2002-03-25       Impact factor: 25.606

3.  Lipopolysaccharides from periodontopathic bacteria Porphyromonas gingivalis and Capnocytophaga ochracea are antagonists for human toll-like receptor 4.

Authors:  Atsutoshi Yoshimura; Takashi Kaneko; Yoshifumi Kato; Douglas T Golenbock; Yoshitaka Hara
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

4.  Induction of keratinocyte growth factor 1 Expression by lipopolysaccharide is regulated by CD-14 and toll-like receptors 2 and 4.

Authors:  Edward E Putnins; Ali-Reza Sanaie; Qiang Wu; James D Firth
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

5.  Ammonium hydroxide hydrolysis: a valuable support in the MALDI-TOF mass spectrometry analysis of Lipid A fatty acid distribution.

Authors:  Alba Silipo; Rosa Lanzetta; Angela Amoresano; Michelangelo Parrilli; Antonio Molinaro
Journal:  J Lipid Res       Date:  2002-12       Impact factor: 5.922

6.  Differential induction of endotoxin tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli.

Authors:  M Martin; J Katz; S N Vogel; S M Michalek
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

7.  Two lipoproteins extracted from Escherichia coli K-12 LCD25 lipopolysaccharide are the major components responsible for Toll-like receptor 2-mediated signaling.

Authors:  Hyun-Ku Lee; Jongdae Lee; Peter S Tobias
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

Review 8.  Porphyromonas gingivalis lipopolysaccharide signaling in gingival fibroblasts-CD14 and Toll-like receptors.

Authors:  P-L Wang; K Ohura
Journal:  Crit Rev Oral Biol Med       Date:  2002

9.  Porphyromonas gingivalis lipopolysaccharide antagonizes Escherichia coli lipopolysaccharide at toll-like receptor 4 in human endothelial cells.

Authors:  Stephen R Coats; Robert A Reife; Brian W Bainbridge; T Thu-Thao Pham; Richard P Darveau
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

10.  Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature.

Authors:  Kazuyoshi Kawahara; Hiroko Tsukano; Haruo Watanabe; Buko Lindner; Motohiro Matsuura
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

View more
  180 in total

1.  Free lipid A isolated from Porphyromonas gingivalis lipopolysaccharide is contaminated with phosphorylated dihydroceramide lipids: recovery in diseased dental samples.

Authors:  Frank C Nichols; Bekim Bajrami; Robert B Clark; William Housley; Xudong Yao
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

Review 2.  Animal models to study host-bacteria interactions involved in periodontitis.

Authors:  Dana T Graves; Jun Kang; Oelisoa Andriankaja; Keisuke Wada; Carlos Rossa
Journal:  Front Oral Biol       Date:  2011-11-11

3.  Porphyromonas gulae Activates Unprimed and Gamma Interferon-Primed Macrophages via the Pattern Recognition Receptors Toll-Like Receptor 2 (TLR2), TLR4, and NOD2.

Authors:  James A Holden; Neil M O'Brien-Simpson; Jason C Lenzo; Rebecca K H Orth; Ashley Mansell; Eric C Reynolds
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

4.  Supernatants from oral epithelial cells and gingival fibroblasts modulate human immunodeficiency virus type 1 promoter activation induced by periodontopathogens in monocytes/macrophages.

Authors:  O A González; J L Ebersole; C B Huang
Journal:  Mol Oral Microbiol       Date:  2010-04       Impact factor: 3.563

5.  Serine dipeptide lipids of Porphyromonas gingivalis inhibit osteoblast differentiation: Relationship to Toll-like receptor 2.

Authors:  Yu-Hsiung Wang; Reza Nemati; Emily Anstadt; Yaling Liu; Young Son; Qiang Zhu; Xudong Yao; Robert B Clark; David W Rowe; Frank C Nichols
Journal:  Bone       Date:  2015-09-25       Impact factor: 4.398

6.  A novel class of lipoprotein lipase-sensitive molecules mediates Toll-like receptor 2 activation by Porphyromonas gingivalis.

Authors:  Sumita Jain; Stephen R Coats; Ana M Chang; Richard P Darveau
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

7.  Lipopolysaccharide and IL-1β coordinate a synergy on cytokine production by upregulating MyD88 expression in human gingival fibroblasts.

Authors:  Colleen W Brinson; Zhongyang Lu; Yanchun Li; Maria F Lopes-Virella; Yan Huang
Journal:  Mol Immunol       Date:  2016-09-30       Impact factor: 4.407

Review 8.  Modulating LPS signal transduction at the LPS receptor complex with synthetic Lipid A analogues.

Authors:  Aileen F B White; Alexei V Demchenko
Journal:  Adv Carbohydr Chem Biochem       Date:  2014       Impact factor: 12.200

9.  Proteomic mapping of stimulus-specific signaling pathways involved in THP-1 cells exposed to Porphyromonas gingivalis or its purified components.

Authors:  Julian A Saba; Mark E McComb; Donna L Potts; Catherine E Costello; Salomon Amar
Journal:  J Proteome Res       Date:  2007-05-04       Impact factor: 4.466

10.  Acyl chain specificity of the acyltransferases LpxA and LpxD and substrate availability contribute to lipid A fatty acid heterogeneity in Porphyromonas gingivalis.

Authors:  Brian W Bainbridge; Lisa Karimi-Naser; Robert Reife; Fleur Blethen; Robert K Ernst; Richard P Darveau
Journal:  J Bacteriol       Date:  2008-05-02       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.